Old drug gets an absurd price hike to $89,000 per year

@ 2017/02/13
Martin Shkreli doesn't have a monopoly on jacking up drug prices. Marathon Pharmaceuticals has received FDA approval for an old drug used to treat Duchenne muscular dystrophy, deflazacort, and in the process has raised the price to ridiculously high...

No comments available.